申请人:Merck & Co., Inc.
公开号:US06500844B1
公开(公告)日:2002-12-31
The present invention is directed to compounds of the formula I:
(wherein R1, R2, R3, R7, R8, X, Y, Z, x and y are defined herein) which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptors CCR-5 and/or CCR-3.
本发明涉及化合物的公式I:(其中R1、R2、R3、R7、R8、X、Y、Z、x和y如本文所定义),这些化合物可用作化学因子受体活性的调节剂。具体来说,这些化合物可用作化学因子受体CCR-5和/或CCR-3的调节剂。